EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study

Paula Nistor, Ionica Iancu, Vlad Iorgoni, Alexandru Gligor, Alexandra Blaga, Janos Degi, Livia Stângă, Tiana Suici, Viorel Herman

Pathogens · 06.11.2026 · 15 (11) · 1164

DOI: 10.3390/pathogens15111164 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pathogens, online erschienen am 06.11.2026. Verfasst von Paula Nistor und 8 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic progressive lymphedema (CPL) in draft horses is frequently complicated by secondary cutaneous infection, and Pseudomonas aeruginosa may be difficult to eliminate. This study evaluated topical 2% acetic acid as an adjunct to a standardized local treatment protocol.

Methods

Records of 35 hospitalized horses with CPL in which P. aeruginosa was the sole pretreatment isolate were reviewed retrospectively. Seven historical controls received clipping, chlorhexidine cleansing, drying, and polyhexanide irrigation; 28 horses received the same protocol plus 2% acetic acid twice daily. No horse received systemic antimicrobials. Follow-up cultures were collected 24 h after clinical resolution.

Results

Median treatment duration was 12 days (IQR 11–14) in controls and 8 days (IQR 7–9) with acetic acid (p < 0.001). P. aeruginosa clearance was achieved in 1/7 (14.3%) and 27/28 (96.4%) horses, respectively (p < 0.001). Subsequent clinical reappearance of P. aeruginosa-associated disease occurred in 6/7 (85.7%) and 3/28 (10.7%) horses (p < 0.001); most control events reflected persistence rather than recurrence after clearance. No local adverse reactions were recorded.

Conclusions

Adding topical 2% acetic acid was associated with higher P. aeruginosa clearance, shorter treatment, and fewer subsequent clinical reappearances. Prospective randomized studies are needed to confirm these findings.

Zitieren

APA

Nistor, P., Iancu, I., Iorgoni, V., Gligor, A., Blaga, A., Degi, J., Stângă, L., Suici, T., & Herman, V. (2026). Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study. Pathogens, 15(11), 1164. https://doi.org/10.3390/pathogens15111164

Vancouver

Nistor P, Iancu I, Iorgoni V, Gligor A, Blaga A, Degi J, et al. Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study. Pathogens. 2026;15(11):1164. doi:10.3390/pathogens15111164

BibTeX
@article{Nistor2026,
  author = {Nistor, Paula and Iancu, Ionica and Iorgoni, Vlad and Gligor, Alexandru and Blaga, Alexandra and Degi, Janos and Stângă, Livia and Suici, Tiana and Herman, Viorel},
  title = {Clinical and Microbiological Outcomes of Topical 2% Acetic Acid as an Adjunct to Standardized Treatment for Pseudomonas aeruginosa-Associated Secondary Cutaneous Disease in Horses with Chronic Progressive Lymphedema: A Retrospective Historical-Control Cohort Study},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1164},
  doi = {10.3390/pathogens15111164}
}
Kostenlos starten →